Early administration of moderate-dose dexamethasone `is not indicated' in extremely low birthweight neonates

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1271, 2001-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Postnatal HRT beneficial in very low birthweight neonates

By  

Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite

Lenalidomide + low-dose dexamethasone may master MM

By  

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Myalgia in Patients on High‐Dose and Low‐to‐Moderate Dose Statin Therapy

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 3, 2009-09 ,pp. : 202-206

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early, high-dose thyroxine benefits neonates with CH?

By  

Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite